申请人:SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
公开号:EP1245561A1
公开(公告)日:2002-10-02
N-(3,5-bis-disubstituted aminomethyl-4-hydroxy)benzyl aromatic sulfonamides and N-(3,5-bis-disubstituted aminomethyl-4-hydroxy)phenyl aromatic sulfonamides compounds in accordance with the animal test, are active in the prevention and the treatment of cardiac arrhythmia. These compounds are prepared as corresponding diamines by the condensation of optionally substituted aromatic sulfochlorides with p-hydroxybenzylamine, p-aminophenol, or the like, which followed by the Mannich reaction of the resulted corresponding aromatic sulfamides with formaldehyde and secondary amines; or directly obtained by the reaction of the aromatic sulfamides with 4-amino-2,6-bis-disubstituted aminomethylphenol. Subsequently, the diamines are reacted with various acids to provide their salts.
根据动物试验,N-(3,5-二取代氨甲基-4-羟基)苄基芳香族磺酰胺和 N-(3,5-二取代氨甲基-4-羟基)苯基芳香族磺酰胺化合物在预防和治疗心律失常方面具有活性。这些化合物是通过任选取代的芳香族磺酰氯与对羟基苄胺、对氨基苯酚或类似物缩合,然后将生成的相应芳香族磺酰胺与甲醛和仲胺进行曼尼希反应制备成相应的二胺;或者直接通过芳香族磺酰胺与 4-氨基-2,6-二取代氨甲基苯酚反应制备成二胺。随后,二胺与各种酸反应生成它们的盐。